SRNE - Sorrento Therapeutics' CEO Henry Ji on the Status of the Company's 3 COVID-19 Tests
In this video from Motley Fool Live recorded on Nov. 12, Sorrento Therapeutics ' (NASDAQ: SRNE) chairman, president, and CEO Henry Ji and senior vice president of regulatory affairs Mark Brunswick discuss the company's three COVID-19 tests. None of the tests have gained an Emergency Use Authorization from the Food and Drug Administration yet, but the executives expect to submit applications -- or update an old application -- for all three tests fairly soon.
For further details see:
Sorrento Therapeutics' CEO Henry Ji on the Status of the Company's 3 COVID-19 Tests